X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (419) 419
Newsletter (84) 84
Publication (83) 83
Newspaper Article (25) 25
Book Review (4) 4
Book Chapter (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rifapentine (478) 478
tuberculosis (303) 303
index medicus (206) 206
humans (204) 204
rifampin (141) 141
pulmonary tuberculosis (115) 115
infectious diseases (109) 109
female (105) 105
pharmacology & pharmacy (101) 101
rifampin - analogs & derivatives (98) 98
drug therapy (94) 94
antitubercular agents - therapeutic use (93) 93
respiratory system (93) 93
male (89) 89
mycobacterium-tuberculosis (88) 88
microbiology (87) 87
rifabutin (84) 84
pharmacokinetics (81) 81
isoniazid (80) 80
moxifloxacin (80) 80
rifampin - administration & dosage (76) 76
tuberculosis - drug therapy (73) 73
adult (69) 69
dosage and administration (66) 66
drug therapy, combination (64) 64
antitubercular agents - administration & dosage (63) 63
health aspects (63) 63
treatment outcome (63) 63
animals (62) 62
infection (60) 60
research (59) 59
rifampicin (58) 58
tuberculosis, pulmonary - drug therapy (58) 58
rifampin - therapeutic use (52) 52
middle aged (51) 51
mycobacterium tuberculosis - drug effects (51) 51
care and treatment (48) 48
infections (48) 48
drug administration schedule (47) 47
immunology (47) 47
pyrazinamide (47) 47
medical research (46) 46
hiv (45) 45
medicine, general & internal (42) 42
latent tuberculosis (41) 41
medicine, experimental (41) 41
mycobacterium tuberculosis (41) 41
regimens (41) 41
therapy (41) 41
mice (39) 39
rifampin - pharmacokinetics (39) 39
chemotherapy (38) 38
prevention (38) 38
rifamycins (38) 38
analysis (37) 37
clinical trials (37) 37
isoniazid - administration & dosage (37) 37
antitubercular agents (36) 36
once-weekly rifapentine (36) 36
critical care medicine (35) 35
latent tuberculosis - drug therapy (35) 35
risk factors (35) 35
abridged index medicus (34) 34
rifampin - adverse effects (34) 34
antitubercular agents - pharmacology (33) 33
drugs (33) 33
isoniazid - therapeutic use (33) 33
adults (32) 32
article (31) 31
united-states (31) 31
human immunodeficiency virus--hiv (30) 30
rifampin - pharmacology (30) 30
diagnosis (29) 29
public health (29) 29
adolescent (28) 28
antitubercular agents - adverse effects (28) 28
drug resistance (28) 28
early bactericidal activity (28) 28
medicine (28) 28
antibiotics, antitubercular - administration & dosage (27) 27
bactericidal activity (27) 27
epidemiology (27) 27
multidrug-resistant tuberculosis (27) 27
antitubercular agents - pharmacokinetics (26) 26
dose-response relationship, drug (26) 26
drug dosages (26) 26
patients (26) 26
latent tuberculosis infection (25) 25
pharmacology (25) 25
preventive therapy (25) 25
time factors (24) 24
aged (23) 23
intellectual property (23) 23
microbial sensitivity tests (23) 23
treatment (23) 23
tuberculosis - microbiology (22) 22
isoniazid - adverse effects (21) 21
mice, inbred balb c (21) 21
models (21) 21
tuberculosis, multidrug-resistant - drug therapy (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (517) 517
French (3) 3
Russian (3) 3
Spanish (3) 3
Chinese (2) 2
German (1) 1
Italian (1) 1
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Respiratory Journal, ISSN 0903-1936, 02/2019, Volume 53, Issue 2
Journal Article
The European respiratory journal, ISSN 0903-1936, 12/2018, Volume 52, Issue 6
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1599 - 1608
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2000, Volume 46, Issue 4, pp. 565 - 570
The in vitro activity of rifapentine and its metabolite, 25-O-desacetylrifapentine, as compared with that of rifampicin and rifabutin, was determined against... 
rifapentine
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2000, Volume 46, Issue 4, pp. 571 - 576
The in vitro activity of rifapentine for 44 clinical isolates of Mycobacterium tuberculosis complex was compared with that of rifampicin using the Bactec... 
rifapentine
Journal Article
Infectious Diseases in Clinical Practice, ISSN 1056-9103, 09/2017, Volume 25, Issue 5, pp. 272 - 274
BACKGROUNDLatent tuberculosis infection treatment is a cornerstone of tuberculosis control. Standard treatment is 9 months of daily, self-administered... 
completion | 3HP | latent tuberculosis | rifapentine
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 01/2017, Volume 64, Issue 1, pp. 105 - 105
Journal Article
Journal of the Pediatric Infectious Diseases Society, ISSN 2048-7193, 06/2014, Volume 3, Issue 2, pp. 132 - 145
Background In a phase 3, randomized clinical trial (PREVENT TB) of 8053 people with latent tuberculosis infection, 12 once-weekly doses of rifapentine and... 
Treatment | Tuberculosis | Children | Pharmacokinetics | Rifapentine
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 03/2016, Volume 30, Issue 10, pp. 1607 - 1615
OBJECTIVE:Compare the effectiveness, tolerability, and safety of three months of weekly rifapentine plus isoniazid under direct observation (3HP) vs. 9 months... 
isoniazid | HIV | latent tuberculosis | rifapentine | M. tuberculosis
Journal Article
European Respiratory Journal, ISSN 0903-1936, 11/2018, Volume 52, Issue 5
Ensuring adherence and support during treatment of tuberculosis (TB) is a major public health challenge. Digital health technologies could help improve... 
RESPIRATORY SYSTEM | LATENT | DIRECTLY OBSERVED THERAPY | INFECTION | PATIENT | RIFAPENTINE | BURDEN | MEDICATION ADHERENCE | CARE
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 09/2008, Volume 105, Issue 39, pp. 14820 - 14825
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 10/2016, Volume 9, Issue 10, pp. 1253 - 1261
Introduction: The goal of this article is to review the use of rifapentine in the treatment of latent tuberculosis infection (LTBI). Controlling LTBI is an... 
Latent tuberculosis | mycobacterium tuberculosis | rifamycins | rifapentine | MYCOBACTERIUM-TUBERCULOSIS | ANTITUBERCULOSIS DRUG RIFAPENTINE | 12-DOSE REGIMEN | PROTEIN-BINDING | HIGH-DOSE RIFAPENTINE | PLASMA-CONCENTRATIONS | PREVENT TUBERCULOSIS | POPULATION PHARMACOKINETICS | PULMONARY TUBERCULOSIS | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS
Journal Article
Respiratory Medicine, ISSN 0954-6111, 10/2019, Volume 158, pp. 42 - 48
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2017, Volume 61, Issue 8
Rifamycins exhibit concentration-dependent killing of Mycobacterium tuberculosis; higher exposures potentially induce better outcomes. We randomized 180... 
Antitubercular agents | Tuberculosis | Pharmacokinetics | Rifampin | OPTIMIZE | rifampin | tuberculosis | pharmacokinetics | PULMONARY TUBERCULOSIS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | antitubercular agents | RANGING TRIAL | RIFAPENTINE | MOXIFLOXACIN
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S46
L'objectif de cette etude etait d'etudier les conditions d'isolement et de traitement de la tuberculose (TB) en Europe. Cette etude montre des pratiques... 
Medical research | Tuberculosis | Comorbidity | Medicine, Experimental | Ethambutol | Efavirenz | Rifapentine | Raltegravir
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.